Literature DB >> 9876341

The impact of obesity on cardiovascular risk factors in Turner's syndrome.

M Elsheikh1, G S Conway.   

Abstract

OBJECTIVE: To evaluate risk factors for coronary artery disease in women with Turner's syndrome which may contribute to the increased incidence of premature cardiovascular death noted in this disorder.
DESIGN: Comparison of clinical and biochemical parameters in women with Turner's syndrome with those in women with normal karyotype. PATIENTS: Ninety-one women with Turner's syndrome attending a dedicated adult Turner's syndrome clinic and 22 control subjects were studied. MEASUREMENTS: Recumbent blood pressure, body mass index (BMI), fasting total cholesterol, triglycerides and high density lipoproteins (HDL) were measured in both study groups.
RESULTS: Women with Turner's syndrome were more obese compared with women with a normal karyotype. They were more likely to be hypertensive and the obese patients had higher serum triglyceride concentrations. Hypertension was independent of obesity and may be under-recognized because of failure to compare with age-matched normal ranges. Lipoprotein changes were accounted for by the obesity.
CONCLUSIONS: Women with Turner's syndrome may be at increased risk of developing coronary artery disease as a result of the higher frequency of hypertension and obesity. Routine screening of this population for risk factors for ischaemic heart disease is recommended.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9876341     DOI: 10.1046/j.1365-2265.1998.00552.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  X-chromosome gene dosage and the risk of diabetes in Turner syndrome.

Authors:  Vladimir K Bakalov; Clara Cheng; Jian Zhou; Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

2.  Growth hormone effect on body composition in Turner syndrome.

Authors:  Alexandre Duarte Baldin; Tatiana Fabbri; Adriana Aparecida Siviero-Miachon; Angela Maria Spinola-Castro; Sofia Helena Valente de Lemos-Marini; Maria Tereza Matias Baptista; Lilia Freire Rodrigues D'Souza-Li; Andrea Trevas Maciel-Guerra; Gil Guerra-Junior
Journal:  Endocrine       Date:  2011-07-01       Impact factor: 3.633

3.  Atherogenic lipid profile and systolic blood pressure are associated with carotid artery intima-media thickness in children with Turner syndrome.

Authors:  Özgür Pirgon; Mehmet Emre Atabek; Bülent Oran; Rıdvan Güçlü
Journal:  J Clin Res Pediatr Endocrinol       Date:  2008-11-02

4.  Vasculopathy in the young Turner syndrome population.

Authors:  Sarah A Lawson; Elaine M Urbina; Iris Gutmark-Little; Philip R Khoury; Zhiqian Gao; Philippe F Backeljauw
Journal:  J Clin Endocrinol Metab       Date:  2014-06-24       Impact factor: 5.958

5.  Insulin resistance in adolescents with Turner syndrome is comparable to obese peers, but the overall metabolic risk is lower due to unknown mechanism.

Authors:  M Wojcik; D Janus; A Zygmunt-Gorska; J B Starzyk
Journal:  J Endocrinol Invest       Date:  2014-10-11       Impact factor: 4.256

6.  Turner syndrome and associated problems in Turkish children: a multicenter study.

Authors:  Ediz Yeşilkaya; Abdullah Bereket; Feyza Darendeliler; Firdevs Baş; Şükran Poyrazoğlu; Banu Küçükemre Aydın; Şükran Darcan; Bumin Dündar; Muammer Büyükinan; Cengiz Kara; Erkan Sarı; Erdal Adal; Ayşehan Akıncı; Mehmet Emre Atabek; Fatma Demirel; Nurullah Çelik; Behzat Özkan; Bayram Özhan; Zerrin Orbak; Betül Ersoy; Murat Doğan; Ali Ataş; Serap Turan; Damla Gökşen; Ömer Tarım; Bilgin Yüksel; Oya Ercan; Şükrü Hatun; Enver Şimşek; Ayşenur Ökten; Ayhan Abacı; Hakan Döneray; Mehmet Nuri Özbek; Mehmet Keskin; Hasan Önal; Nesibe Akyürek; Kezban Bulan; Derya Tepe; Hamdi Cihan Emeksiz; Korcan Demir; Deniz Kızılay; Ali Kemal Topaloğlu; Erdal Eren; Samim Özen; Saygın Abalı; Leyla Akın; Beray Selver Eklioğlu; Sultan Kaba; Ahmet Anık; Serpil Baş; Tolga Ünüvar; Halil Sağlam; Semih Bolu; Tolga Özgen; Durmuş Doğan; Esra Deniz Çakır; Yaşar Şen; Nesibe Andıran; Filiz Çizmecioğlu; Olcay Evliyaoğlu; Gülay Karagüzel; Özgür Pirgon; Gönül Çatlı; Hatice Dilek Can; Fatih Gürbüz; Çiğdem Binay; Veysel Nijat Baş; Kürşat Fidancı; Adem Polat; Davut Gül; Cengizhan Açıkel; Hüseyin Demirbilek; Peyami Cinaz; Carolyn Bondy
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-03

7.  Favorable impact of growth hormone treatment on cholesterol levels in turner syndrome.

Authors:  Hitoshi Kohno; Yutaka Igarashi; Keiichi Ozono; Kenji Ohyama; Masamichi Ogawa; Hisao Osada; Kazumichi Onigata; Susumu Kanzaki; Yoshiki Seino; Hiroaki Takahashi; Toshihiro Tajima; Katsuhiko Tachibana; Hiroyuki Tanaka; Yoshikazu Nishi; Tomonobu Hasegawa; Kenji Fujieda; Keinosuke Fujita; Reiko Horikawa; Susumu Yokoya; Toru Yorifuji; Toshiaki Tanaka
Journal:  Clin Pediatr Endocrinol       Date:  2012-03-24

Review 8.  Cardiometabolic and vascular risks in young and adolescent girls with Turner syndrome.

Authors:  Meenal Mavinkurve; Clodagh S O'Gorman
Journal:  BBA Clin       Date:  2015-04-30

Review 9.  Bone Fragility in Turner Syndrome: Mechanisms and Prevention Strategies.

Authors:  Maria Felicia Faienza; Annamaria Ventura; Silvia Colucci; Luciano Cavallo; Maria Grano; Giacomina Brunetti
Journal:  Front Endocrinol (Lausanne)       Date:  2016-04-26       Impact factor: 5.555

10.  Chromosomal abnormalities and atrial fibrillation and ischemic stroke incidence: a nationwide population-based study.

Authors:  Jun Hwan Cho; Eue-Keun Choi; In-Ki Moon; Jin- Hyung Jung; Kyung-Do Han; You-Jung Choi; Jiesuck Park; Euijae Lee; So- Ryoung Lee; Myung-Jin Cha; Woo-Hyun Lim; Seil Oh
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.